Dr Reddys Laboratories Stock Filter Stocks by Fundamentals

RDY Stock  USD 72.31  0.49  0.67%   
Dr Reddys Laboratories fundamentals help investors to digest information that contributes to Dr Reddys' financial success or failures. It also enables traders to predict the movement of RDY Stock. The fundamental analysis module provides a way to measure Dr Reddys' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dr Reddys stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

RDY Number of Shares Shorted Analysis

 2021 2022 2023 2024 (projected)
Other Current Liabilities41.6B48.9B56.2B59.0B
Total Assets296.7B322.9B371.3B206.1B
More About Number of Shares Shorted | All Equity Analysis

RDY Number of Shares Shorted Driver Correlations

Understanding the fundamental principles of building solid financial models for Dr Reddys is extremely important. It helps to project a fair market value of RDY Stock properly, considering its historical fundamentals such as Number of Shares Shorted. Since Dr Reddys' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Dr Reddys' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Dr Reddys' interrelated accounts and indicators.
0.970.96-0.071.0-0.14-0.130.920.990.910.98-0.16-0.2-0.050.961.00.990.990.331.00.040.960.03-0.070.19-0.14-0.180.10.030.020.01
0.971.00.090.97-0.04-0.20.970.960.880.95-0.04-0.160.040.910.970.980.960.320.98-0.090.920.11-0.020.12-0.2-0.140.140.140.120.16
0.961.00.160.96-0.01-0.180.970.930.880.920.02-0.120.10.880.960.970.950.30.96-0.150.90.150.040.07-0.18-0.110.130.20.180.2
-0.070.090.16-0.090.7-0.010.17-0.180.03-0.220.880.540.82-0.28-0.08-0.09-0.1-0.16-0.06-0.85-0.260.690.71-0.550.040.4-0.130.810.820.67
1.00.970.96-0.09-0.16-0.130.910.990.90.98-0.18-0.23-0.060.960.990.990.990.320.990.030.960.03-0.060.24-0.14-0.20.10.030.010.0
-0.14-0.04-0.010.7-0.160.08-0.13-0.230.01-0.270.80.640.86-0.28-0.14-0.19-0.17-0.43-0.15-0.75-0.270.710.73-0.340.120.58-0.620.430.490.22
-0.13-0.2-0.18-0.01-0.130.08-0.28-0.120.19-0.150.310.550.01-0.04-0.17-0.16-0.08-0.27-0.170.19-0.14-0.070.14-0.171.00.42-0.52-0.26-0.23-0.25
0.920.970.970.170.91-0.13-0.280.890.770.89-0.03-0.210.030.810.920.930.90.410.93-0.120.850.11-0.08-0.01-0.27-0.140.310.250.230.3
0.990.960.93-0.180.99-0.23-0.120.890.891.0-0.26-0.26-0.170.980.990.990.980.360.980.160.99-0.1-0.170.27-0.14-0.230.13-0.1-0.12-0.06
0.910.880.880.030.90.010.190.770.890.870.070.140.020.90.890.890.910.130.880.030.870.060.140.170.19-0.02-0.09-0.02-0.01-0.02
0.980.950.92-0.220.98-0.27-0.150.891.00.87-0.31-0.3-0.210.980.980.990.980.380.980.190.99-0.13-0.230.29-0.17-0.250.16-0.13-0.15-0.07
-0.16-0.040.020.88-0.180.80.31-0.03-0.260.07-0.310.850.72-0.32-0.19-0.2-0.18-0.35-0.18-0.7-0.320.70.76-0.490.360.68-0.30.60.640.48
-0.2-0.16-0.120.54-0.230.640.55-0.21-0.260.14-0.30.850.4-0.26-0.23-0.24-0.23-0.34-0.24-0.26-0.270.380.59-0.340.60.75-0.330.180.210.16
-0.050.040.10.82-0.060.860.010.03-0.170.02-0.210.720.4-0.24-0.06-0.11-0.07-0.37-0.04-0.9-0.240.690.76-0.450.040.34-0.530.640.70.3
0.960.910.88-0.280.96-0.28-0.040.810.980.90.98-0.32-0.26-0.240.950.960.970.240.940.240.98-0.16-0.190.38-0.06-0.290.07-0.2-0.22-0.14
1.00.970.96-0.080.99-0.14-0.170.920.990.890.98-0.19-0.23-0.060.950.990.980.351.00.050.960.02-0.10.19-0.18-0.190.120.020.010.0
0.990.980.97-0.090.99-0.19-0.160.930.990.890.99-0.2-0.24-0.110.960.990.990.350.990.080.97-0.03-0.130.22-0.17-0.210.16-0.02-0.040.03
0.990.960.95-0.10.99-0.17-0.080.90.980.910.98-0.18-0.23-0.070.970.980.990.240.980.040.960.02-0.070.24-0.09-0.220.070.01-0.010.0
0.330.320.3-0.160.32-0.43-0.270.410.360.130.38-0.35-0.34-0.370.240.350.350.240.350.30.37-0.34-0.47-0.16-0.29-0.010.51-0.11-0.20.02
1.00.980.96-0.060.99-0.15-0.170.930.980.880.98-0.18-0.24-0.040.941.00.990.980.350.020.950.05-0.080.18-0.18-0.190.130.060.050.03
0.04-0.09-0.15-0.850.03-0.750.19-0.120.160.030.19-0.7-0.26-0.90.240.050.080.040.30.020.24-0.82-0.770.350.15-0.250.3-0.82-0.84-0.47
0.960.920.9-0.260.96-0.27-0.140.850.990.870.99-0.32-0.27-0.240.980.960.970.960.370.950.24-0.19-0.220.33-0.16-0.250.15-0.2-0.23-0.12
0.030.110.150.690.030.71-0.070.11-0.10.06-0.130.70.380.69-0.160.02-0.030.02-0.340.05-0.82-0.190.7-0.17-0.030.42-0.260.780.820.45
-0.07-0.020.040.71-0.060.730.14-0.08-0.170.14-0.230.760.590.76-0.19-0.1-0.13-0.07-0.47-0.08-0.77-0.220.7-0.080.170.26-0.390.640.640.32
0.190.120.07-0.550.24-0.34-0.17-0.010.270.170.29-0.49-0.34-0.450.380.190.220.24-0.160.180.350.33-0.17-0.08-0.21-0.570.08-0.35-0.4-0.29
-0.14-0.2-0.180.04-0.140.121.0-0.27-0.140.19-0.170.360.60.04-0.06-0.18-0.17-0.09-0.29-0.180.15-0.16-0.030.17-0.210.46-0.52-0.22-0.19-0.21
-0.18-0.14-0.110.4-0.20.580.42-0.14-0.23-0.02-0.250.680.750.34-0.29-0.19-0.21-0.22-0.01-0.19-0.25-0.250.420.26-0.570.46-0.270.130.150.04
0.10.140.13-0.130.1-0.62-0.520.310.13-0.090.16-0.3-0.33-0.530.070.120.160.070.510.130.30.15-0.26-0.390.08-0.52-0.270.130.040.28
0.030.140.20.810.030.43-0.260.25-0.1-0.02-0.130.60.180.64-0.20.02-0.020.01-0.110.06-0.82-0.20.780.64-0.35-0.220.130.130.970.76
0.020.120.180.820.010.49-0.230.23-0.12-0.01-0.150.640.210.7-0.220.01-0.04-0.01-0.20.05-0.84-0.230.820.64-0.4-0.190.150.040.970.68
0.010.160.20.670.00.22-0.250.3-0.06-0.02-0.070.480.160.3-0.140.00.030.00.020.03-0.47-0.120.450.32-0.29-0.210.040.280.760.68
Click cells to compare fundamentals
Competition

Based on the recorded statements, Dr Reddys Laboratories has 0.0null of outstending shares currently sold short by investors. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Number of Shares Shorted (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Portfolio Diagnostics Now

   

Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
All  Next Launch Module

RDY Fundamentals

About Dr Reddys Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Dr Reddys Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dr Reddys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dr Reddys Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Reddys Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 24795 people.

Currently Active Assets on Macroaxis

When determining whether Dr Reddys Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dr Reddys' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Reddys Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Reddys Laboratories Stock:
Check out Dr Reddys Piotroski F Score and Dr Reddys Altman Z Score analysis.
Note that the Dr Reddys Laboratories information on this page should be used as a complementary analysis to other Dr Reddys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for RDY Stock analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
CEOs Directory
Screen CEOs from public companies around the world
Is Dr Reddys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dr Reddys. If investors know RDY will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dr Reddys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.103
Dividend Share
40
Earnings Share
3.75
Revenue Per Share
272.4618
Quarterly Revenue Growth
0.066
The market value of Dr Reddys Laboratories is measured differently than its book value, which is the value of RDY that is recorded on the company's balance sheet. Investors also form their own opinion of Dr Reddys' value that differs from its market value or its book value, called intrinsic value, which is Dr Reddys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dr Reddys' market value can be influenced by many factors that don't directly affect Dr Reddys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dr Reddys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dr Reddys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dr Reddys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.